Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Trial exclusion patterns Phase 2 and Phase 3 retatrutide trials commonly excluded participants with a history of pancreatitis, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), severe gastroparesis, recent major cardiovascular events, severe kidney impairment, type 1 diabetes (in the obesity studies), and pregnancy or breastfeeding
It is unknown whether WEGOVY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined [see Warnings and Precautions ( 5.1 ), Nonclinical Toxicology ( 13.1 )]
Rosenstock J, Frias JP, Jastreboff AM, et al
Expertly engineered for progressive metabolic support, this premium injection pen delivers a highly pure 2mg concentration of active Semaglutide
Stress Management: Practices like mindfulness, meditation, and adequate sleep can reduce cortisol levels, complementing the medications ability to improve metabolic function
US$ 22.82
US$ 23.98
US$ 26.19
US$ 24.28
US$ 26.37
US$ 22.85
